GLEEVEC vs VERZENIO

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 18, 2026·How we rate

Possible drug interaction. GLEEVEC and VERZENIO are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	GLEEVEC	VERZENIO
Rating	70/100	New
Pharmacy pays	~$25.80 /30	—
Type	RX	RX
Active ingredient	IMATINIB MESYLATE	ABEMACICLIB
Manufacturer	Novartis	Eli Lilly and Co
Dosage forms	Tablet	Tablet
Drug class	Kinase Inhibitor	Kinase Inhibitor
Boxed warning	None	None
Treats	Lymphoid Leukemia, Myeloid Leukemia, Hypereosinophilic Syndrome	Breast Neoplasms

gleevec verzenio

Rating

70/100

New

Pharmacy pays

~$25.80 /30

—

Type

Active ingredient

IMATINIB MESYLATE

ABEMACICLIB

Manufacturer

Novartis

Eli Lilly and Co

Dosage forms

Tablet

Drug class

Kinase Inhibitor

Boxed warning

None

Treats

Lymphoid Leukemia, Myeloid Leukemia, Hypereosinophilic Syndrome

Breast Neoplasms

Frequently asked questions

What is the difference between Gleevec and Verzenio?

Gleevec contains Imatinib Mesylate, while Verzenio contains Abemaciclib — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.